RUNX3 and cancer: Several pioneer studies have discussed the probable restoration of RUNX3 and a reduced carcinogenic potential in cancer cell lines when treated with demethylating drugs (Lau et al., 2006; Jung, Park, Young Kim, et al., 2007).